Jessica Petro-Sakuma, DO
Hospitalist · Salina, KSNPI 1295268860
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,188 and has fallen 91.8% since, to $97 in 2025. Among hospitalist clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 104 payments — averaging $21.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$514
- Biohaven Pharmaceuticals, Inc.$354
- Amgen$290
- Lilly USA, LLC$249
- Akcea Therapeutics, Inc.$195
- AbbVie$133
- plus $535 from 13 others
What the payments were for
- Food & beverage$2,271100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 23 | $514 |
| Biohaven Pharmaceuticals, Inc. | 17 | $354 |
| Amgen | 18 | $290 |
| Lilly USA, LLC | 15 | $249 |
| Akcea Therapeutics, Inc. | 3 | $195 |
| AbbVie | 5 | $133 |
| Amarin Pharma, Inc. | 3 | $108 |
| GSK | 1 | $83 |
| Pfizer | 3 | $79 |
| Merck | 3 | $43 |
| Johnson & Johnson | 2 | $42 |
| Chiasma, Inc. | 1 | $40 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Eisai Inc. | 2 | $30 |
| Bayer | 2 | $28 |
| AstraZeneca | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Mayne Pharma Commercial LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,271 in reported general payments places this provider in the 95th percentile of 178 hospitalist providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Tartrate | 20 | $203 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Salina
- Drew RoseSalina$492
- Jeffrey RobinsonSalina$71
- Abhiram DuvvuriTopeka$5K
- Mohinder VindhyalKansas City$4K
- Sreekar VennelagantiOverland Park$3K
- Caleb BowersWichita$2K
- Paul NdundaWichita$1K
- Melissa MiddlemasOverland Park$811
- Molly VanpettenAtchison$698
- Ronak ShahOlathe$587
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.